Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1949 1
1987 1
1990 1
1994 1
2000 1
2013 1
2017 1
2024 1
2026 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

8 results

Results by year

Citations

1 article found by citation matching

Search results

Filters applied: . Clear all
Page 1
Doxorubicin-associated flare reactions.
Curran CF, Luce JK, Page JA. Curran CF, et al. Oncol Nurs Forum. 1990 May-Jun;17(3):387-9. Oncol Nurs Forum. 1990. PMID: 2342972
Local urticaria occurred in 133 patients (25%), and 35 patients (6%) reported either vein pain or a stinging sensation. In 20 cases (4%), erythema in the region immediately surrounding the infusion site accompanied the primary manifestation of erythema along the cou …
Local urticaria occurred in 133 patients (25%), and 35 patients (6%) reported either vein pain or a stinging sensation. In 20 …
Effect of the Use of Buzzy® during Phlebotomy on Pain and Individual Satisfaction in Blood Donors.
Yılmaz D, Heper Y, Gözler L. Yılmaz D, et al. Pain Manag Nurs. 2017 Aug;18(4):260-267. doi: 10.1016/j.pmn.2017.03.005. Epub 2017 Jun 7. Pain Manag Nurs. 2017. PMID: 28601479
For the nonintervention control group, no intervention was implemented before the procedure. Immediately after entry to the vein, pain levels and levels of phlebotomy satisfaction were assessed in individuals in all groups. ...
For the nonintervention control group, no intervention was implemented before the procedure. Immediately after entry to the vein, …
[Sympathetic vein (pain) sensibility].
VAN GELDEREN C. VAN GELDEREN C. Geneeskd Gids. 1949 Oct 6;27(20):385-93. Geneeskd Gids. 1949. PMID: 15393086 Dutch. No abstract available.
[Safety and efficacy analysis of a varicose vein sealant kit in the treatment of great saphenous vein dysfunction].
Zou SL, Zhi KK, Hong Y, Guo LR, Qi YX, Zhang L, Peng JL, Ye B, Zheng GF, Hao B, Xu HM, Chen B, Pan YF, Zhu YF, Wu JJ, Huang XJ, Wen SC, Wang X, Qu LF. Zou SL, et al. Zhonghua Yi Xue Za Zhi. 2024 Sep 10;104(35):3334-3341. doi: 10.3760/cma.j.cn112137-20231208-01323. Zhonghua Yi Xue Za Zhi. 2024. PMID: 39266498 Clinical Trial. Chinese.
The secondary outcome measures were the complete closure rate of the great saphenous vein in both groups of patients immediately after surgery and 6 months after surgery, the operation time for closing the main trunk of the great saphenous vein, pain score, venous c …
The secondary outcome measures were the complete closure rate of the great saphenous vein in both groups of patients immediately after surge …
Visceral pain threshold is deeply lowered far from the head in migraine.
Nicolodi M, Sicuteri R, Coppola G, Greco E, Pietrini U, Sicuteri F. Nicolodi M, et al. Headache. 1994 Jan;34(1):12-9. doi: 10.1111/j.1526-4610.1994.hed3401012.x. Headache. 1994. PMID: 8132435
The injection of 1 mL of 2% to 8% (i.e. 0.34 mol/L to 1.36 mol/L) hypertonic saline into the antecubital vein during an extemporary short (1 minute) circulatory blockage (ischemia induced to guarantee a strictly local action of the chemical stimulus) provokes moderate, strong or …
The injection of 1 mL of 2% to 8% (i.e. 0.34 mol/L to 1.36 mol/L) hypertonic saline into the antecubital vein during an extemporary short (1 …
A dose-response study of intravenous enoximone in congestive heart failure.
Erbel R, Meyer J, Diefenbach C, Delorme G, Bourdarias JP, Vernant P, Lellouche D, Mattioli G, Barbieri A, Installe E, et al. Erbel R, et al. Am J Cardiol. 1987 Aug 14;60(5):31C-36C. doi: 10.1016/0002-9149(87)90522-4. Am J Cardiol. 1987. PMID: 2956865 Clinical Trial.
Eighteen adverse reactions were reported by 15 patients, of which 11 were minor and transient (vein pain, flushes, nausea). In 5 patients ventricular or supraventricular arrhythmias were observed, including nonsustained ventricular tachycardia and extrasystoles; 3 o …
Eighteen adverse reactions were reported by 15 patients, of which 11 were minor and transient (vein pain, flushes, nausea). In …
Phase II study of the oxygen saturation curve left shifting agent BW12C in combination with the hypoxia activated drug mitomycin C in advanced colorectal cancer.
Propper DJ, Levitt NC, O'Byrne K, Braybrooke JP, Talbot DC, Ganesan TS, Thompson CH, Rajagopalan B, Littlewood TJ, Dixon RM, Harris AL. Propper DJ, et al. Br J Cancer. 2000 Jun;82(11):1776-82. doi: 10.1054/bjoc.2000.1138. Br J Cancer. 2000. PMID: 10839290 Free PMC article. Clinical Trial.
The predominant toxicities--nausea/vomiting and vein pain--were mild and did not exceed CTC grade 2. Liver 31P magnetic resonance spectroscopy of patients with hepatic metastases showed no changes consistent with tissue hypoxia. ...
The predominant toxicities--nausea/vomiting and vein pain--were mild and did not exceed CTC grade 2. Liver 31P magnetic resona …
[A case of advanced rectal cancer with bladder carcinoma salvaged from myocardial infarction during operation, showing tumor regression by XELOX treatment, good quality of life].
Okumura K, Tani S, Shiogai Y, Kodama M, Mekata E, Tani T. Okumura K, et al. Gan To Kagaku Ryoho. 2013 Jan;40(1):111-3. Gan To Kagaku Ryoho. 2013. PMID: 23306931 Japanese.
Capecitabine(2, 000mg/m / 2, biweekly)plus oxaliplatin(130mg/m2, day 1)was selected. At first, he complained of peripheral vein pain. The speed of oxaliplatin infusion was slowed and the pain was relieved. He had Grade 3 platelet decrease, but the number improved af …
Capecitabine(2, 000mg/m / 2, biweekly)plus oxaliplatin(130mg/m2, day 1)was selected. At first, he complained of peripheral vein pa